Chen Katz
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
- Molecular Biology top 10%
- RNA modifications and cancer
- RNA and protein synthesis mechanisms
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Cell death mechanisms and regulation
- Studies on Chitinases and Chitosanases
Papers in
-
- Cell death mechanisms and regulation 5
- Ubiquitin and proteasome pathways 3
- Epigenetics and DNA Methylation 3
- RNA modifications and cancer 3
- Oncology 10
- Cancer-related Molecular Pathways 8
- Co-authors
- Assaf Friedler (9 shared papers)Eliora Z. Ron (6 shared papers)Stefan Rüdiger (3 shared papers)Shahar Rotem‐Bamberger (3 shared papers)Carol Prives (6 shared papers)Tiago Rito (1 shared paper)Francesca Berini (1 shared paper)Morena Casartelli (1 shared paper)
- Journals
- Proceedings of the National Academy of Sciences (4 papers)PLoS ONE (3 papers)Journal of Biological Chemistry (2 papers)Vaccine (2 papers)Biotechnology Advances (1 paper)
- Partner nations
- IsraelUnited StatesNetherlands
In The Last Decade
Chen Katz
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 84
- Oncology 307
- Molecular Biology 749
- Biotechnology 63
- Cancer Research 89
- Clinical Biochemistry 27
Countries citing papers authored by Chen Katz
This map shows the geographic impact of Chen Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Katz more than expected).
Fields of papers citing papers by Chen Katz
This network shows the impact of papers produced by Chen Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Katz. The network helps show where Chen Katz may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Katz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 176 | |
| 2 | 2011 | 154 | |
| 3 | 2010 | 131 | |
| 4 | 2018 | 109 | |
| 5 | Dose-response studies with a pure tumor-promoting agent, phorbol myristate acetate. | 1973 | 61 |
| 6 | 2014 | 54 | |
| 7 | 2008 | 51 | |
| 8 | 2008 | 44 | |
| 9 | 2008 | 36 | |
| 10 | 2012 | 33 | |
| 11 | 2021 | 31 | |
| 12 | 2018 | 27 | |
| 13 | 2011 | 25 | |
| 14 | 2010 | 25 | |
| 15 | 2023 | 21 | |
| 16 | 2009 | 19 | |
| 17 | 2013 | 15 | |
| 18 | 2005 | 13 | |
| 19 | 2009 | 8 | |
| 20 | 2021 | 6 |
About Chen Katz
Chen Katz is a scholar working on Molecular Biology, Oncology, Immunology, Clinical Biochemistry and Genetics, having authored 27 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), Cell death mechanisms and regulation (5 papers), Ubiquitin and proteasome pathways (3 papers), Advanced Glycation End Products research (3 papers), Epigenetics and DNA Methylation (3 papers), Cancer Research and Treatments (3 papers), RNA modifications and cancer (3 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Oncology (307 citations), Molecular Biology (749 citations), Biotechnology (63 citations), Cancer Research (89 citations) and Clinical Biochemistry (27 citations). Chen Katz has collaborated with scholars based in Israel, United States and Netherlands. Frequent co-authors include Assaf Friedler, Eliora Z. Ron, Stefan Rüdiger, Shahar Rotem‐Bamberger, Carol Prives, Tiago Rito, Francesca Berini, Morena Casartelli, Gianluca Tettamanti and Flavia Marinelli. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE, Journal of Biological Chemistry, Vaccine and Biotechnology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.